# BRISTOL-MYERS SQUIBB COMPANY (BMY) FY2024 YTD Q3 P&L / Income Statement - Company: BRISTOL-MYERS SQUIBB COMPANY (BMY) - Period: 2024-01-01 to 2024-09-30 - Filing: Q3 FY2024 10-Q, filed 2024-10-31, accession number 0000014272-24-000147 - Page: https://plicit.ai/financials/bmy/fy2024-ytd-q3-income-statement - Chart image: https://plicit.ai/charts/bmy-fy2024-ytd-q3-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2024-01-01 through 2024-09-30. View: Product and service (Disaggregation of Revenue by Product and Region). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 35,958,000,000 US dollars - **Cost of products sold**: 9,156,000,000 US dollars - **Gross profit (calculated)**: 26,802,000,000 US dollars - **Operating expenses (calculated)**: 35,356,000,000 US dollars - **Operating profit (calculated)**: negative 8,554,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(loss) before income taxes**: negative 8,554,000,000 US dollars - **Income tax provision**: 455,000,000 US dollars - **Net earnings/(loss)**: negative 9,009,000,000 US dollars - **Opdivo**: 6,825,000,000 US dollars - **Orencia**: 2,682,000,000 US dollars - **Yervoy**: 1,855,000,000 US dollars - **Reblozyl**: 1,226,000,000 US dollars - **Opdualag**: 674,000,000 US dollars - **Abecma**: 301,000,000 US dollars - **Zeposia**: 408,000,000 US dollars - **Breyanzi**: 484,000,000 US dollars - **Camzyos**: 379,000,000 US dollars - **Sotyktu**: 163,000,000 US dollars - **Augtyro**: 23,000,000 US dollars - **Krazati**: 87,000,000 US dollars - **Other Growth products**: 1,093,000,000 US dollars - **Eliquis**: 10,138,000,000 US dollars - **Revlimid**: 4,434,000,000 US dollars - **Pomalyst/Imnovid**: 2,722,000,000 US dollars - **Sprycel**: 1,088,000,000 US dollars - **Abraxane**: 701,000,000 US dollars - **Other Legacy products**: 675,000,000 US dollars - **Marketing, selling and administrative**: 6,278,000,000 US dollars - **Research and development**: 7,968,000,000 US dollars - **Acquired IPRD**: 13,343,000,000 US dollars - **Amortization of acquired intangible assets**: 7,179,000,000 US dollars - **Other (income)/expense, net**: 588,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/bmy/fy2024-ytd-q3-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/bmy-fy2024-ytd-q3-revenue-by-product-and-service-2-sankey.png Income statement for 2024-01-01 through 2024-09-30. View: Product and service (Disaggregation of Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 35,958,000,000 US dollars - **Cost of products sold**: 9,156,000,000 US dollars - **Gross profit (calculated)**: 26,802,000,000 US dollars - **Operating expenses (calculated)**: 35,356,000,000 US dollars - **Operating profit (calculated)**: negative 8,554,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(loss) before income taxes**: negative 8,554,000,000 US dollars - **Income tax provision**: 455,000,000 US dollars - **Net earnings/(loss)**: negative 9,009,000,000 US dollars - **Net product sales**: 34,967,000,000 US dollars - **Alliance revenues**: 355,000,000 US dollars - **Other revenues**: 636,000,000 US dollars - **Marketing, selling and administrative**: 6,278,000,000 US dollars - **Research and development**: 7,968,000,000 US dollars - **Acquired IPRD**: 13,343,000,000 US dollars - **Amortization of acquired intangible assets**: 7,179,000,000 US dollars - **Other (income)/expense, net**: 588,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/bmy/fy2024-ytd-q3-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/bmy-fy2024-ytd-q3-revenue-by-geography-sankey.png Income statement for 2024-01-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 35,958,000,000 US dollars - **Cost of products sold**: 9,156,000,000 US dollars - **Gross profit (calculated)**: 26,802,000,000 US dollars - **Operating expenses (calculated)**: 35,356,000,000 US dollars - **Operating profit (calculated)**: negative 8,554,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(loss) before income taxes**: negative 8,554,000,000 US dollars - **Income tax provision**: 455,000,000 US dollars - **Net earnings/(loss)**: negative 9,009,000,000 US dollars - **UNITED STATES**: 25,509,000,000 US dollars - **International**: 9,803,000,000 US dollars - **Other**: 646,000,000 US dollars - **Marketing, selling and administrative**: 6,278,000,000 US dollars - **Research and development**: 7,968,000,000 US dollars - **Acquired IPRD**: 13,343,000,000 US dollars - **Amortization of acquired intangible assets**: 7,179,000,000 US dollars - **Other (income)/expense, net**: 588,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (3) - Page: https://plicit.ai/financials/bmy/fy2024-ytd-q3-income-statement/revenue-by-product-and-service-3 - Chart image: https://plicit.ai/charts/bmy-fy2024-ytd-q3-revenue-by-product-and-service-3-sankey.png Income statement for 2024-01-01 through 2024-09-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 35,958,000,000 US dollars - **Cost of products sold**: 9,156,000,000 US dollars - **Gross profit (calculated)**: 26,802,000,000 US dollars - **Operating expenses (calculated)**: 35,356,000,000 US dollars - **Operating profit (calculated)**: negative 8,554,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(loss) before income taxes**: negative 8,554,000,000 US dollars - **Income tax provision**: 455,000,000 US dollars - **Net earnings/(loss)**: negative 9,009,000,000 US dollars - **Net product sales**: 34,967,000,000 US dollars - **Alliance and other revenues**: 991,000,000 US dollars - **Marketing, selling and administrative**: 6,278,000,000 US dollars - **Research and development**: 7,968,000,000 US dollars - **Acquired IPRD**: 13,343,000,000 US dollars - **Amortization of acquired intangible assets**: 7,179,000,000 US dollars - **Other (income)/expense, net**: 588,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (4) - Page: https://plicit.ai/financials/bmy/fy2024-ytd-q3-income-statement/revenue-by-product-and-service-4 - Chart image: https://plicit.ai/charts/bmy-fy2024-ytd-q3-revenue-by-product-and-service-4-sankey.png Income statement for 2024-01-01 through 2024-09-30. View: Product and service (Reconciliation of Gross Product Sales to Net Product Sales). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Total Revenues**: 35,958,000,000 US dollars - **Cost of products sold**: 9,156,000,000 US dollars - **Gross profit (calculated)**: 26,802,000,000 US dollars - **Operating expenses (calculated)**: 35,356,000,000 US dollars - **Operating profit (calculated)**: negative 8,554,000,000 US dollars - **Other income (expense), net (calculated)**: 0 US dollars - **Earnings/(loss) before income taxes**: negative 8,554,000,000 US dollars - **Income tax provision**: 455,000,000 US dollars - **Net earnings/(loss)**: negative 9,009,000,000 US dollars - **Gross product sales**: 61,298,000,000 US dollars - **Net product sales**: 34,967,000,000 US dollars - **Marketing, selling and administrative**: 6,278,000,000 US dollars - **Research and development**: 7,968,000,000 US dollars - **Acquired IPRD**: 13,343,000,000 US dollars - **Amortization of acquired intangible assets**: 7,179,000,000 US dollars - **Other (income)/expense, net**: 588,000,000 US dollars - **Revenue before reconciliation (calculated)**: 96,265,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation. - **Components above reported revenue (calculated)**: negative 60,307,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. - Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.